Neumora drops as depression therapy fails in late-stage trial
Watertown | massachusetts |
|
|
Neumora Therapeutics (NMRA) crashed after its Phase 3 study for its lead asset navacaprant in major depressive disorder didn't meet main goals. Read more here.[...]
Jan 02, 2025 03:22am | 1 view | source: Bing / Seeking Alpha
|
|